A Case Report: Disseminated AIDs-related Kaposi Sarcoma
Keywords:
Kaposi's Sarcoma,, HIV,, Purple rash,, Antiretroviral drugs,, Kaposi SarcomaAbstract
Background: Kaposi sarcoma (KS) is a vascular tumor associated with the Human Herpesvirus-8 (HHV-8) virus and is common in patients with advanced HIV infection, especially those with low CD4 lymphocyte counts. It can occur in the skin, oral mucosa, lungs, and gastrointestinal tract, which has a high mortality rate.
Objective: To report a case study of an HIV patient diagnosed with invasive Kaposi sarcoma and emphasize the importance of diagnosis through skin lesion examination to prevent disease spread.
Method: We present a case study of a 25-year-old male patient who presented with chronic shortness of breath for 1 week and a purplish lesion in the oral cavity with skin rash for 1 month. The diagnosis was confirmed by biopsy results of skin and oral lesions and pathological examinations that showed characteristics of Kaposi sarcoma.
Results: This case report is a case report of invasive Kaposi sarcoma in an HIV patient from a regional hospital in Thailand. The patient was a 25-year-old homosexual male. A patient came to the hospital with shortness of breath for 1 week and a lump on the gums, along with a purple rash for 1 month. This patient was diagnosed with metastatic Kaposi's sarcoma. Later, the patient died from complications resulting from starting antiretroviral therapy and receiving chemotherapy at Songklanagarind Hospital. The purpose of writing this article is to consider the diagnosis in skin examination as a part of helping in diagnosing the disease and preventing it from spreading later if diagnosed early.
Conclusion: Early detection of skin lesions is important for diagnosing and preventing the spread of Kaposi's sarcoma in HIV patients. In addition, early initiation of antiretroviral therapy plays an important role in reducing the mortality rate of patients.
References
Sewon K, Masayuki A, Anna L, Alexander H, David J, Amy J, et al. Kaposi sarcoma. Fitzpatrick’s Dermatology 9th ed. New York: McGraw-Hill Education; 2019:3119.
American Cancer Society. What is Kaposi Sarcoma? 2018. Available from: https://www.cancer.org/cancer/kaposi-sarcoma/about/what-is-kaposi-sarcoma.html
worldwideLiu Z, Fang Q, Zuo J, Minhas V, Wood C, Zhang T. The world-wide incidence of Kaposi's sarcoma in the HIV/AIDS era. HIV medicine. 2018;19:355-364. Available from: https://doi.org/10.1111/hiv.12584
Mehta S, Garg A, Gupta LK, Mittal A, Khare AK, Kuldeep CM. Kaposi's sarcoma as a presenting manifestation of HIV. Indian J Sex Transm Dis AIDS. 2011;32(2):108-110. Available from: 10.4103/2589-0557.85415.
Abdulrhaman FA, Nael MH. HIV-Associated Cutaneous Kaposi's Sarcoma. Cureus 13(2);2021. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7905740/.
Bruce JD. Management of AIDS-related Kaposi's sarcoma: advances in target discovery and treatment. Expert Rev of Anticancer Ther. 2002(2):193-200. Available from: 10.1586/14737140.2.2.193.
Jean B, Julie S, Lorenzo C. Human Herpesvirus type 8. Fourth Edition Dermatology. Elsevier Limited; 2018:1421-1422.
Aversa SML, Cattelan AM, Salvagno L, Crivellari G, Banna G, Trevenzoli M, et al. Treatments of AIDS-related Kaposi's sarcoma. Crit Rev Oncol Hematol. Elsevier B.V. 2005;53(3):253-65. Available from: 10.1016/j.critrevonc.2004.10.009.
Dhilon T, Stebbing J, Bower M. Paclitaxel for AIDS-associated Kaposi’s sarcoma. Expert Review of Anticancer Therapy. 2005;5(2); 215–219. Available from doi:10.1586/14737140.5.2.215.
Schneider WJ, Dittmer PD. Diagnosis and Treatment of Kaposi Sarcoma. American journal of clinical Dermatology. Am J Clin Dermatol. 2017;18(4): 529–39. Available from: 10.1007/s40257-017-0270-4.
Speicher DJ, Sehu MM, Johnson NW, Shaw DR. Successful treatment of an HIV-positive patient with unmasking Kaposi's sarcoma immune reconstitution inflammatory syndrome. J Clin Virol. Elsevier B.V. 2013;57(3):282-5. Available from: 10.1016/j.jcv.2013.03.005.
Bower M, Nelson M, Young AM, Thirlwell C, Newsom-Davis T, Mandalia S, et al. Immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma. J Clin Oncol. 2005;23(22). Available from: doi: 10.1200/JCO.2005.14.597.
Grabar S, Abraham B, Mahamat A, Del Giudice P, Rosenthal E, Costagliola D. Differential impact of combination antiretroviral therapy in preventing Kaposi's sarcoma with and without visceral involvement. Journal of clinical oncology. J Clin Oncol. 2006;24(21):3408-14. Availble from: 10.1200/JCO.2005.05.4072.
Rohner E, Bütikofer L, Schmidlin K, Sengayi M, Maskew M, Giddy J, et al. Comparison of Kaposi Sarcoma Risk in Human Immunodeficiency Virus-Positive Adults Across 5 Continents: A Multiregional Multicohort Study. Clin Infect Dis. 2017;65(8): 1316–26. Available from: https://doi.org/10.1093/cid/cix480.
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.